Samir Nagi Khalil, BSW | |
4160 Ocoee St N Ste 8, Cleveland, TN 37312-4886 | |
(423) 464-4357 | |
Not Available |
Full Name | Samir Nagi Khalil |
---|---|
Gender | Male |
Speciality | Social Worker |
Location | 4160 Ocoee St N Ste 8, Cleveland, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194329722 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YS0200X | Counselor - School | (* (Not Available)) | Secondary |
104100000X | Social Worker | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Samir Nagi Khalil, BSW 4160 Ocoee St N Ste 8, Cleveland, TN 37312-4886 Ph: (423) 464-4357 | Samir Nagi Khalil, BSW 4160 Ocoee St N Ste 8, Cleveland, TN 37312-4886 Ph: (423) 464-4357 |
News Archive
GE Healthcare today announced results from its ongoing customer evaluation of Gemstone Spectral Imaging, a technology aiming to enhance CT's diagnostic capability. Gemstone Spectral Imaging is an available option for Discovery CT750HD systems and is being delivered to customers worldwide.
Nektar Therapeutics announced today that it has received a $40 million cash payment under a license agreement with AstraZeneca. The payment was triggered by the first commercial sale of MOVENTIG (naloxegol) in Germany.
The University of Virginia and the Wallace H. Coulter Foundation have teamed to create a $20 million endowment to foster research collaboration between biomedical engineers and clinicians, with the goal of developing new technologies to improve patient care and human health.
It's tough being the parent of a child with food allergies. Constant vigilance is needed for everything your child eats, when a single food item containing a hidden ingredient can be fatal.
Haemonetics Corporation today announced the expiration of the subsequent offering period for the cash tender offer by its wholly-owned subsidiary Atlas Acquisition Corp. for Global Med Technologies, Inc.'s outstanding shares of common stock, at $1.22 per share, and preferred stock, at $1,694.44 per share.
› Verified 6 days ago